Demand for meningococcal meningitis treatment will increase through 2036, with bacterial causes at 71.5% of the causative micro-organism segment in 2026. The market was valued at USD 196.08 million in 2025 and is expected to be worth USD 324.81 million by 2036, creating an incremental opportunity of USD 119.62 million.